Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04956640 |
|
Recruitment Status :
Recruiting
First Posted : July 9, 2021
Last Update Posted : May 3, 2024
|
Sponsor:
Eli Lilly and Company
Collaborators:
Loxo Oncology, Inc.
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Eli Lilly and Company
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2025 |
| Estimated Study Completion Date : | September 2025 |